Immunological therapy of sepsis: experimental therapies.
about
Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa.Concept of the aortic aneurysm repair-related surgical stress: a review of the literature.Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis.Novel therapies for sepsis: antiendotoxin therapies.Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis.Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.Immunomodulatory effects of fosfomycin in experimental human endotoxemia.The importance of fever as a predictive symptom for the potency of host's monocytes to release pro- and anti-inflammatory mediatorsImmunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa.Cytokine removal with a novel adsorbent polymer.Hypothermia and surgery: immunologic mechanisms for current practice.Controversies in host defense against surgical site infection.Impaired energy metabolism during neonatal sepsis: the effects of glutamine.A combination of thalidomide and augmentin protects BALB/c mice suffering from Klebsiella pneumoniae B5055-induced sepsis.Clarithromycin: immunomodulatory therapy of experimental sepsis and acute pyelonephritis by Escherichia coli.Antithrombotic agents in the treatment of severe sepsis.Secretory phospholipase A2 in newborn infants with sepsis
P2860
Q24812750-CE88F7EC-E483-4AB2-B8D3-C190DCA268D1Q25257156-5D4789C0-2DE3-4690-BC38-12C4C2919EE0Q34414854-1462FF4A-F358-4D65-954A-306252C738F6Q34443368-57CDF686-950E-4100-B81F-80EB9D66DC2FQ35011910-E4DB2A34-0962-443D-8161-6CF6E4EE13B7Q35104932-DE02B0FC-EAE6-4A38-8682-37113F063F5EQ35166127-AD46379F-9AA2-4421-AF45-423C22EA6A77Q35759103-4AFE0629-421A-4338-95ED-482E569E1099Q36513681-AD9FE0B0-80E3-4CC5-BB38-706B68D813F6Q38935459-5545BDC1-D3E7-4419-B7D3-C18EB94E65A8Q40410604-BBC603BF-E043-488A-AAA0-2C3103C395DFQ40524481-49FEF861-ACB8-4E06-913B-E6AC40AA39F5Q42136197-4BE9BF4B-B0D7-49FC-8B93-5BF64B28A34BQ43250301-93C2915B-32BF-4013-B8F6-E74CC94D5387Q44704082-38910A0D-74A8-4833-9FB8-EBB99551A8CBQ46021286-B8B4E0B9-EC71-436C-988A-B790B8137510Q46374860-22CDDBFD-37CC-4EDE-952A-98F4DEA740CAQ46576624-E66DFC57-A241-4201-9121-5F47CE195333Q59317130-3A7BEFA9-7EEB-4E8D-BB40-B11E541E9E97
P2860
Immunological therapy of sepsis: experimental therapies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunological therapy of sepsis: experimental therapies.
@ast
Immunological therapy of sepsis: experimental therapies.
@en
Immunological therapy of sepsis: experimental therapies.
@nl
type
label
Immunological therapy of sepsis: experimental therapies.
@ast
Immunological therapy of sepsis: experimental therapies.
@en
Immunological therapy of sepsis: experimental therapies.
@nl
prefLabel
Immunological therapy of sepsis: experimental therapies.
@ast
Immunological therapy of sepsis: experimental therapies.
@en
Immunological therapy of sepsis: experimental therapies.
@nl
P356
P1476
Immunological therapy of sepsis: experimental therapies.
@en
P2093
P2888
P304
P356
10.1007/S001340000574
P478
27 Suppl 1
P577
2001-01-01T00:00:00Z